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THE TREATMENT AND EMPLOYABILITY OF THE EPILEPTIC
W I L L I A M C . NOSHAY, M.D.'''

The care of the epileptic patient is primarily one of medical therapy, and the
magnitude of the problem is emphasized by the fact that it is estimated that there are
approximately one mfllion epileptics in this country.
The medical management of cerebral seizures has been complicated as wefl as
benefited by the relatively recent addition of a number of new anti-convulsants. It is
noteworthy that none of the new drugs have proved to be more generally effective or
safe than Dilantin and Phenobarbital, either alone or in combination.
Although there is some degree of drug specificity in regard to the treatment
of the various types of seizures, it is generally advisable in adults to start the patient
on Dilantin. This is especially true in the management of grand mal or major seizures.
If an average dose of Dilantin, which is three of four one and one-half grain capsules
per day, does not control the attacks, Phenobarbital should then be added. A bedtime
dose of one grain may be added to the Dilantin, and if this is inadequate additional
daytime dosages of Phenobarbital should be given. Because of the relative safety of
these medications, they should be increased to the point of intoxication before other
medications are used. It is to be noted that in an occasional sensitive patient Dilantin
may cause marked nystagmus or even diplopia, gross ataxia, minor gastrointestinal
disturbances and, rarely, a drug dermatitis.
True petit mal seizures, which consist only of a transient staring spell, rarely occur
in adults except in association with other forms of seizures. For these the addition of
Tridione, Paradione or Milontin may be necessary. These medications should not be
given in adults excepts in combination with Dilantin or Phenobarbital, and periodic
blood counts are advisable in view of the possible occurrence of blood dyscrasias.
Temporal lobe seizures in the form of automatisms, psychic attacks or minor
epileptic equivalents are usually difficult to control. I f a combination of Dilantin and
Phenobarbital is unsatisfactory, the addition of Mesantoin may be beneficial. Phenurone
has proven to be more specific for these attacks than other anti-convulsants, but this
drug is usuafly held in reserve because of the rare occurrence of serious liver damage,
in addition to the possibility of blood dyscrasia and more commonly encountered
psychic changes. When Phenurone is used it is customary to obtain periodic blood
checks as well as liver function studies. This is one of the more dangerous anticonvulsants, but to the present its toxicity would appear to be over-emphasized. Mysoline, one of the more recent medications, may be of more than ordinary benefit in the
control of psychomotor seizures, and Mebarol and the Diones have been beneficial
in some cases.
Symptomatic seizures, those which result from some demonstrable brain lesion,
are best treated with Dilantin and Phenobarbital. In some cases, surgery is indicated
when a focal epileptogenic lesion is demonstrable, and the attacks cannot be controlled
on medication. Unmanageable psychomotor or temporal lobe seizures have also been
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treated surgically by the removal of the anterior temporal lobe in those cases showing
an epileptogenic focus in the electroencephalogram.
There are some noteworthy general facts regarding the use and misuse of anticonvulsants. It is well known, but occasionally overlooked, that of all the commonly
used barbiturates, only Phenobarbital has a specific anti-convulsant action. It is to
be noted, however, that two other anti-convulsants, Mebarol and Gemonil, are
barbiturate derivatives.
The commonest errors in the use of anti-convulsants are faflure to prescribe
adequate dosage, and frequent switching of medications without giving the drugs a
sufficient trial alone or in combination with other drugs.
If the prescribed treatment does result in complete control of seizures it is
important that the medication be continued for a minimum of two years following
cessation of the attacks, and in many patients it may be advisable to continue treatment indefinitely. If it is felt that treatment can be discontinued, the anti-convulsants
should be decreased gradually over a period of a year or more, and in no case should
any of the medications be stopped abruptly, because of the possibility of precipitating
an attack.
There are other factors in addition to drug therapy to be considered in the treatment
and management of epileptic patients. Special attention should be directed to the
handling of emotional problems and maintenance of good general health. The use of
alcohol should be discouraged since this may be a primary cause or act as a trigger
in the precipitation of seizures. Except for the avoidance of potentially dangerous
situations there is no cause to limit the activity of the epileptic.
When a suitable program of treatment affording satisfactory control of seizures
has been reached, the problem of rehabilitation remains to be solved. Although considerable progress has been made in removing the social stigma attached to the epileptic,
he often finds the problem of obtaining employment a hopeless task unless he conceals
the knowledge of his illness. When he does obtain a job he anticipates discharge, on
the grounds of there being no suitable work available, should an attack occur while
at work.
There is obviously great need for further understanding as well as regulation
of the employability of the epileptic. Seizure patients are not virtue of their disorder any more accident-prone than other employees. The seizures of up to 50 per
cent or more of epileptic patients can be completely controlled, and there would
appear to be no reason to limit in any way the employment of these patients so long
as they continue under treatment and periodic medical supervision.
Compensable injuries are not a problem in the controlled epfleptic, and they
should not be a significant problem in the uncontrolled epileptic with suitable job
placement. The patient who continues to have an occasional seizure should not be
placed on a job which presents a special hazard to him or his fellow-employees
should an attack occur. There undoubtedly are many epileptics currently working
on undesirable jobs because they have concealed the knowledge of their fliness. Serious
accidents are surprisingly uncommon as a result of such circumstances, but this
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situation would not arise, if the epfleptic were given equal opportunity to obtain employment despite his iflness.
It is unlikely that such practice would affect any significant change in workmen's compensation costs. In the known epfleptic the occasional minor injury which
results directly from an attack does not present a compensation problem, and there
is usually little time lost from work on this account.
In a recent study of laws affecting epileptics, Fabing and Barrow^ suggested that
this employment problem would be largely resolved by placing compensable injuries
to the epfleptic under the "second injury" fund, which has been established to
permit the employment of handicapped persons without undue liability risk to the
employer.
If the employment office can be opened to the epileptic as it should be, a major
barrier to his rehabilitation will be removed and with the drugs avaflable today the
majority of these people can be given the opportunity to lead a reasonably normal life.
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